×
ADVERTISEMENT

Alzheimer's disease

FDA Approves Kisunla to Treat Early Alzheimer’s Disease

The FDA approved donanemab-azbt injection for the treatment of Alzheimer’s disease in patients who have mild ...

JULY 3, 2024

Viagra: Potent Remedy for Memory Loss?

A recent study found an association with a reduced risk for Alzheimer’s disease and erectile dysfunction ...

FEBRUARY 9, 2024

Biogen Pulls the Plug on Alzheimer’s Drug Aducanumab

Biogen announced on Jan. 31 that it would abandon the development and commercialization of aducanumab (Aduhelm), ...

FEBRUARY 2, 2024

Can Vaccination Reduce Risk for Alzheimer’s?

Prior vaccination against tetanus and diphtheria—with or without pertussis—herpes zoster and ...

SEPTEMBER 8, 2023

CMS Will Cover 80% Of Leqembi Cost; No Trial Entry Needed

With the FDA having granted full traditional approval to the anti-amyloid Alzheimer’s disease drug ...

AUGUST 17, 2023

Medicare Patients Move Closer to Receiving Coverage for Leqembi

Medicare patients are only a few steps away from being covered for Leqembi, a drug that has demonstrated a ...

JUNE 29, 2023

What Causes Alzheimer’s?

Most efforts at finding a cure for Alzheimer’s disease, the most common cause of dementia among the elderly, ...

AUGUST 13, 2019

Unusually High Levels of HHV Found in the Brains of Those With Alzheimer’s

HHV-6A and HHV-7 are found in the brains of people with Alzheimer’s disease at levels up to twice as high as ...

JULY 10, 2018

U.S. Death Rates From Alzheimer’s Disease Increased 55% From 1999 to 2014

More caregiver support needed as disease burden grows.

MAY 26, 2017

Load more